The 8th Glioblastoma Drug Development Summit explores approaches in glioblastoma drug development, focusing on innovative treatments, diagnostics, and clinical trial strategies.
Key Topics
Overcoming the blood-brain barrier in glioblastoma treatments
Advancing imaging techniques and biomarkers for glioblastoma diagnosis
Optimizing immunotherapy and addressing the tumor microenvironment
Unlocking the potential of combination therapies for glioblastoma
Transforming glioblastoma clinical trial frameworks for future success
Exploring new technologies and upcoming therapies disrupting current paradigms
Insights into funding and partnerships for glioblastoma research
Who should Attend
Oncologists and clinical researchers specializing in glioblastoma
Biotech and pharmaceutical professionals focusing on brain cancer treatments
Medical imaging and biomarker development experts
Regulatory professionals and clinical trial coordinators
Investors and funding organizations supporting glioblastoma research
